Table 1.
Characteristics of study cohort.
| Normal Histology * | Steatosis ** | Inflammation *** | Fibrosis **** | |
|---|---|---|---|---|
| N | 36 | 50 | 52 | 53 |
| M/F | 5/31 | 11/39 | 8/44 | 14/39 |
| Age (y) ± SD | 44.6 ± 9.8 | 44.0 ± 11.1 | 43.7 ±12.7 | 49.1 ± 10.3 |
| BMI (kg/m2) ± SD | 43.4 ± 6.2 | 46.7 ± 10.0 | 48.7 ± 7.8 | 49.5 ± 11.1 |
| T2D (N) | 9 | 18 | 14 | 36 |
* Absence of inflammation, fibrosis, and ≤5% steatosis; ** grade 2: >33–66% parenchymal involvement by steatosis, and grade 3: >66% parenchymal involvement by steatosis; *** grade 1: <2 lobular inflammatory loci per 200× field), grade 2: 2–4 lobular inflammatory loci per 200× field); **** grade 3: bridging fibrosis, grade 3/4: incomplete cirrhosis, and grade 4: cirrhosis.